Mehmet Mutlu Kıdı

16PUBLICATIONS
95CO-AUTHORS
Predictive and prognostic markersNutrigenomics and personalised nutritionCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsComputational linguistics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Oct 16, 2026
Prognostic Value of Pretreatment Modified Glasgow Prognostic Score in Nivolumab-Treated Advanced Non-Small Cell Lung Cancer.

|Sep 26, 2026
Prognostic Value of the Modified Glasgow Prognostic Score in Patients with Metastatic Renal Cell Carcinoma Receiving Nivolumab as Second-Line Therapy: A Multicentre Retrospective Cohort Study.

|Sep 26, 2026
Is There a Tumor Proportion Score Threshold at Which Tumor-Cell PD-L1 Adds Prognostic Information Beyond the International Prognostic Index in Large B-Cell Lymphoma?

|Aug 27, 2026
Quantitative Immunohistochemical Landscapes and Chemoimmunotherapy Outcomes of ASCL1, NEUROD1, POU2F3, and YAP1 in Pure Small-Cell Lung Cancer: A Pilot Study.

|Jul 15, 2026
Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study.

|Jun 26, 2026
Dose-Adjusted EPOCH-R in Aggressive B-Cell Lymphomas: Efficacy, Molecular Prognostic Factors, and Real-World Outcomes from a Multicenter Turkish Cohort-A Turkish Oncology Group (TOG) Study.

Pageof 3

Frequent Collaborators

10 joint publications

Ertuğrul Bayram

9 joint publications

Sedat Biter

7 joint publications

Mahmut Buyuksimsek

6 joint publications

Hatice Asoglu